Pfizer Inc. (NYSE: PFE) today announced that it has commenced a consent
solicitation to amend certain provisions of the indentures governing the
following outstanding debt securities (the Securities) of Pharmacia
Corporation
Buy Advair Diskus (Fluticasone-Salmeterol) pills online without prescription.
Pfizer is soliciting consents from holders of record of the Securities
as of 5:00 p.m., New York City time, on August 14, 2012. In order for
the proposed amendments to be adopted with respect to the 6.50%
Debentures due 2018 and the 6.60% Debentures due 2028, consents must be
received from the holders of at least a majority (greater than 50%) in
principal amount of the outstanding Securities of each such series
affected by the proposed amendments. In order for the proposed
amendments to be adopted with respect to the 6.47% Notes due 2018, the
8.70% Debentures due 2021 and the 6.75% Debentures due 2027, consents
must be received from the holders of at least 66 2/3%
in principal amount of the outstanding Securities of each such series
affected by the proposed amendments. If the proposed amendments are
approved with respect to a series of Securities, Pfizer will make a
payment to each holder of such series who validly delivers its consent
prior to the expiration of the consent solicitation and does not validly
revoke such consent of $2.50 for each $1,000 principal amount of
Securities to which such consent relates. The solicitation will expire
at 5:00 p.m., New York City time, on August 23, 2012, unless extended.
The detailed terms and conditions of the consent solicitation are set
forth in a Consent Solicitation dated August 15, 2012 and the related
Letter of Consent, each to be sent to record holders of the Securities.
J.P. Morgan will act as Solicitation Agent for the consent solicitation.
D.F. King will act as the Information and Tabulation Agent.
This announcement is for informational purposes only and is not an offer
to purchase or sell, a solicitation of an offer to purchase or sell, or
a solicitation of consents with respect to any securities. The
solicitation is being made solely pursuant to the above-described
Consent Solicitation dated August 15, 2012 and the related Letter of
Consent.
The solicitation of consents is not being made in any jurisdiction in
which, or to or from any person to or from whom, it is unlawful to make
such solicitation under applicable state or foreign securities or “blue
sky” laws.
Pfizer Inc: Working together for a healthier world™
At Pfizer, we apply science and our global resources to improve health
and well-being at every stage of life. We strive to set the standard for
quality, safety and value in the discovery, development and
manufacturing of medicines for people and animals. Our diversified
global health care portfolio includes human and animal biologic and
small molecule medicines and vaccines, as well as nutritional products
and many of the world’s best-known consumer products. Every day, Pfizer
colleagues work across developed and emerging markets to advance
wellness, prevention, treatments and cures that challenge the most
feared diseases of our time. Consistent with our responsibility as the
world’s leading biopharmaceutical company, we also collaborate with
health care providers, governments and local communities to support and
expand access to reliable, affordable health care around the world. For
more than 150 years, Pfizer has worked to make a difference for all who
rely on us.
No comments:
Post a Comment